Literature DB >> 16143895

Examination of changes in TGF-beta1 and KL-6 expression over time in patients with chronic hepatitis C by AT-II receptor blocker therapy.

Takeshi Kurihara, Atsushi Maeda, Mutsuo Shigemoto, Katsuko Yamashita.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16143895     DOI： 10.1007/s00535-004-1643-z

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN： 0944-1174            Impact factor:   7.527


× No keyword cloud information.
  7 in total

1.  Angiotensin II induces contraction and proliferation of human hepatic stellate cells.

Authors:  R Bataller; P Ginès; J M Nicolás; M N Görbig; E Garcia-Ramallo; X Gasull; J Bosch; V Arroyo; J Rodés
Journal:  Gastroenterology       Date:  2000-06       Impact factor: 22.682

2.  KL-6, a human MUC1 mucin, is chemotactic for human fibroblasts.

Authors:  Y Hirasawa; N Kohno; A Yokoyama; Y Inoue; M Abe; K Hiwada
Journal:  Am J Respir Cell Mol Biol       Date:  1997-10       Impact factor: 6.914

3.  Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats.

Authors:  H Yoshiji; S Kuriyama; J Yoshii; Y Ikenaka; R Noguchi; T Nakatani; H Tsujinoue; H Fukui
Journal:  Hepatology       Date:  2001-10       Impact factor: 17.425

4.  Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II.

Authors:  Ramón Bataller; Pau Sancho-Bru; Pere Ginès; José M Lora; Amal Al-Garawi; Manel Solé; Jordi Colmenero; Josep M Nicolás; Wladimiro Jiménez; Nadine Weich; José-Carlos Gutiérrez-Ramos; Vicente Arroyo; Juan Rodés
Journal:  Gastroenterology       Date:  2003-07       Impact factor: 22.682

5.  The clinical significance of serum KL-6 levels in patients with type C liver diseases.

Authors:  Mitsuhiko Moriyama; Hiroshi Matsumura; Morio Mikuni; Yasuo Arkawa; Shuh Ohshiro; Hiroshi Aoki; Hiroaki Yamagami; Miki Kaneko; Atsuo Shioda; Hiroshi Saito; Naohide Tanaka; Yasuyuki Arakawa
Journal:  Hepatol Res       Date:  2003-04       Impact factor: 4.288

6.  Clinical significance of KL-6, a marker of interstitial pneumonia, in cases of HCV-associated chronic liver disease.

Authors:  Kazutomo Suzuki; Hiroshi Takada; Shigeki Oka; Satoshi Kanouzawa; Mamoru Iimuro; Yoshinori Kitazumi; Takeshi Arima; Rie Ohyama; Hajime Kuwayama
Journal:  Intern Med       Date:  2003-08       Impact factor: 1.271

7.  Reduced plasma transforming growth factor-beta1 levels in patients with chronic hepatitis C after interferon-alpha therapy: association with regression of hepatic fibrosis.

Authors:  H Tsushima; S Kawata; S Tamura; N Ito; Y Shirai; S Kiso; Y Doi; A Yamada; O Oshikawa; Y Matsuzawa
Journal:  J Hepatol       Date:  1999-01       Impact factor: 25.083
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.